AKL-3

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAKL-3
Drug Alias NameAKL-3
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMucin inhibitors
TargetsMucin
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAKL Research & Development Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAKL Research & Development Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A